Serum Adiponectin Predicts COVID-19 Severity

被引:2
|
作者
Pavel, Vlad [1 ]
Raeth, Ulrich [1 ]
Schmid, Stephan [1 ]
Krautbauer, Sabrina [2 ]
Keller, Dennis [1 ]
Amend, Pablo [1 ]
Mueller, Martina [1 ]
Mester, Patricia [1 ]
Buechler, Christa [1 ]
机构
[1] Univ Hosp Regensburg, Dept Internal Med Gastroenterol Hepatol Endocrinol, D-93053 Regensburg, Germany
[2] Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany
关键词
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19; ADIPOSE-TISSUE; EXPRESSION; MORTALITY; MARKERS; OBESITY; SEPSIS;
D O I
10.3390/biomedicines12051043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adiponectin is primarily known for its protective role in metabolic diseases, and it also possesses immunoregulatory properties. Elevated levels of adiponectin have been observed in various inflammatory diseases. However, studies investigating adiponectin levels in the serum of COVID-19 patients have yielded conflicting results. This study aimed to assess serum adiponectin levels in 26 healthy controls, as well as in 64 patients with moderate and 60 patients with severe COVID-19, to determine a potential association between serum adiponectin and the severity of COVID-19. Serum adiponectin levels in severe COVID-19 patients were significantly lower than in those with moderate disease and healthy controls, who exhibited similar serum adiponectin levels. Among patients with moderate disease, positive correlations were observed between serum adiponectin and C-reactive protein levels. Of note, serum adiponectin levels of severe COVID-19 cases were comparable between patients with and without dialysis or vasopressor therapy. Superinfection with bacteria did not exert a notable influence on serum adiponectin levels in patients with severe disease. Patients who were diagnosed with severe COVID-19 and vancomycin-resistant enterococci bacteremia showed a significant reduction in their serum adiponectin levels. An analysis conducted on the entire cohort, including both moderate and severe COVID-19 patients, showed that individuals who did not survive had lower serum adiponectin levels when compared to those who survived. In summary, this study highlights a decrease in serum adiponectin levels in severe COVID-19 cases, indicating the potential utility of adiponectin as an additional biomarker for monitoring disease severity in COVID-19 or critical illnesses in general.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Serum uric acid, disease severity and outcomes in COVID-19
    Inès Dufour
    Alexis Werion
    Leila Belkhir
    Anastazja Wisniewska
    Marie Perrot
    Julien De Greef
    Gregory Schmit
    Jean Cyr Yombi
    Xavier Wittebole
    Pierre-François Laterre
    Michel Jadoul
    Ludovic Gérard
    Johann Morelle
    Critical Care, 25
  • [22] GENETIC VARIANTS AND SERUM PROFILES OF CYTOKINES IN COVID-19 SEVERITY
    Alefishat, Eman
    Mousa, Mira
    Albreiki, Mohammed
    Jelinek, Herbert F.
    Al Halwachi, Zainab
    Khalili, Mariam
    Waasia, Fathimathuz
    Uddin, Maimunah
    Al Kaabi, Nawal
    Mahboub, Bassam
    Albataineh, Mohammad T.
    Tay, Guan K.
    Alsafar, Habiba S.
    SHOCK, 2023, 59 (01): : 58 - 65
  • [23] Elevations of serum cancer biomarkers correlate with severity of COVID-19
    Wei, Xiuqi
    Su, Jingyu
    Yang, Kunyu
    Wei, Jiazhou
    Wan, Huimin
    Cao, Xiaoling
    Tan, Wenbin
    Wang, Hui
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (10) : 2036 - 2041
  • [24] Association of serum uric acid levels with COVID-19 severity
    Fang Hu
    Yifan Guo
    Jianghong Lin
    Yingjuan Zeng
    Juan Wang
    Man Li
    Li Cong
    BMC Endocrine Disorders, 21
  • [25] Serum calprotectin as a novel biomarker for severity of COVID-19 disease
    Tezcan Kaya
    Selçuk Yaylacı
    Ahmet Nalbant
    İlhan Yıldırım
    Havva Kocayiğit
    Erdem Çokluk
    Mehmet Ramazan Şekeroğlu
    Mehmet Köroğlu
    Ertuğrul Güçlü
    Irish Journal of Medical Science (1971 -), 2022, 191 : 59 - 64
  • [26] Severity of COVID-19 Patients Predicted by Serum Sphingolipids Signature
    Torretta, Enrica
    Garziano, Micaela
    Poliseno, Mariacristina
    Capitanio, Daniele
    Biasin, Mara
    Santantonio, Teresa Antonia
    Clerici, Mario
    Lo Caputo, Sergio
    Trabattoni, Daria
    Gelfi, Cecilia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (19)
  • [27] Serum uric acid, disease severity and outcomes in COVID-19
    Dufour, Ines
    Werion, Alexis
    Belkhir, Leila
    Wisniewska, Anastazja
    Perrot, Marie
    De Greef, Julien
    Schmit, Gregory
    Yombi, Jean Cyr
    Wittebole, Xavier
    Laterre, Pierre-Francois
    Jadoul, Michel
    Gerard, Ludovic
    Morelle, Johann
    CRITICAL CARE, 2021, 25 (01)
  • [28] Association of serum uric acid levels with COVID-19 severity
    Hu, Fang
    Guo, Yifan
    Lin, Jianghong
    Zeng, Yingjuan
    Wang, Juan
    Li, Man
    Cong, Li
    BMC ENDOCRINE DISORDERS, 2021, 21 (01)
  • [29] Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
    Fernandez-Pato, Asier
    Virseda-Berdices, Ana
    Resino, Salvador
    Ryan, Pablo
    Martinez-Gonzalez, Oscar
    Perez-Garcia, Felipe
    Martin-Vicente, Maria
    Valle-Millares, Daniel
    Brochado-Kith, Oscar
    Blancas, Rafael
    Martinez, Amalia
    Ceballos, Francisco C.
    Bartolome-Sanchez, Sofia
    Joan Vidal-Alcantara, Erick
    Alonso, David
    Blanca-Lopez, Natalia
    Ramirez Martinez-Acitores, Ignacio
    Martin-Pedraza, Laura
    Angeles Jimenez-Sousa, Maria
    Fernandez-Rodriguez, Amanda
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 676 - 688
  • [30] Biological Aging Predicts Vulnerability to COVID-19 Severity in UK Biobank Participants
    Kuo, Chia-Ling
    Pilling, Luke C.
    Atkins, Janice L.
    Masoli, Jane A. H.
    Delgado, Joao
    Tignanelli, Christopher
    Kuchel, George A.
    Melzer, David
    Beckman, Kenneth B.
    Levine, Morgan E.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2021, 76 (08): : E133 - E141